- Aboriginal Affairs
- Arts and Culture
- Economic Development
- Employment and Training
- Intellectual Property
- Internal Trade
- International Development
- Regional Development
- Research and Development
- Science and Technology
Subject Matter Details
Policies or Program
- Advocate for the implementation of a federal diabetes and obesity strategy.
- Commemoration of the 100th anniversary of the discovery of insulin in Canada.
- Support the establishment of a life sciences strategy in Canada
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Canada Foundation for Innovation
Canadian Heritage (PCH)
Finance Canada (FIN)
Global Affairs Canada (GAC)
House of Commons
Indigenous Services Canada (ISC)
Innovation, Science and Economic Development Canada (ISED)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Senate of Canada
No government funding was received during the last completed financial year.
Client Contact Information
101-2476 Argentia Road
Mississauga, ON L5N 6M1
Principal representative of the client
Adam Marsella, DIRECTOR, EXTERNAL AFFAIRS
Parent Company Information
- Novo Nordisk A/S / Novo Nordisk A/S
Coalition Members Information
Novo Nordisk Canada Inc. / Novo Nordisk Canada Inc. is not a coalition.
Person or Organization with a Direct Interest Beneficiary Information
The activities of Novo Nordisk Canada Inc. / Novo Nordisk Canada Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Novo Nordisk Canada Inc. / Novo Nordisk Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
PHIL VON FINCKENSTEIN
Public offices held
PO Box 4659 Station E
OTTAWA, ON K1S 5H8
Consultant Firm and Address
Maple Leaf Strategies
8 York Street, Suite 200
Ottawa, Ontario, ON K1N 5S6